Rezultaty

Perspectives in the treatment of pancreatic adenocarcinoma od Ángel Cid-Arregui

Dokumenty pełnotekstowe

Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality od Chiara De Divitiis

Dokumenty pełnotekstowe

Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* od David M. Goldenberg, Thomas M. Cardillo, Serengulam V. Govindan, Edmund A. Rossi, Robert M. Sharkey

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study od Mitsukuni Suenaga, Nobuyuki Mizunuma, Satoshi Matsusaka, Eiji Shinozaki, Masato Ozaka, Mariko Ogura, Toshiharu Yamaguchi

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Oncolytic reovirus preferentially induces apoptosis in <i>KRAS</i> mutant colorectal cancer cells, and synergizes with irinotecan od Radhashree Maitra, Raviraja N. Seetharam, Lydia Tesfa, Titto Augustine, Lidija Klampfer, Matthew Coffey, John M. Mariadason, Sanjay Goel

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer od Christopher R. Garrett, Tanios Bekaii‐Saab, Theresa Ryan, George A. Fisher, Sally Clive, Petr Kavan, Einat Shacham‐Shmueli, Aby Buchbinder, Richard M. Goldberg

Dokumenty pełnotekstowe

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer od Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas, Amer H. Zureikat, Barry C. Lembersky, Michael K. Gibson, Ronald G. Stoller, Herbert J. Zeh, Nathan Bahary

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation od Jin Hu, Johan Kinn, A. Ali Zirakzadeh, Amir Sherif, Gunnar Norstedt, A-C Wikström, Ola Winqvist

Dokumenty pełnotekstowe

Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1 od Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, David Lam, Anne Charlotte Bernard, Cécile Henry, Sophie de Carné Trécesson, Érick Gamelin, Philippe Juin, Catherine Guette, Olivier Coqueret

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous <scp>FOLFOX</scp> and bevacizumab for patients with unresectable colorectal liver‐limited metastasis... od Robert C.G. Martin, Charles R. Scoggins, Marshall T. Schreeder, William S. Rilling, Christopher J. Laing, Clifton M. Tatum, Lawrence R. Kelly, Ricardo García‐Mónaco, Vivek R. Sharma, Todd S. Crocenzi, Steven M. Strasberg

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Cisplatin and 5‐fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis od Giuseppe Di Lorenzo, Carlo Buonerba, Piera Federico, Sisto Perdonà, Michele Aieta, Pasquale Rescigno, Carmine D’Aniello, Livio Puglia, Antonella Petremolo, Matteo Ferro, Alfredo Marinelli, Giovannella Palmieri, Guru Sonpavde, Vincenzo Mirone, Sabino De Placido

Dokumenty pełnotekstowe

Safety, pharmacokinetics, and activity of EZN‐2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies od Razelle Kurzrock, Sanjay Goel, Jennifer J. Wheler, David S. Hong, Siqing Fu, Keyvan Rezaï, Sonia K. Morgan‐Linnell, Saı̈k Urien, Sridhar Mani, Imran Chaudhary, Mohammed H. Ghalib, Aby Buchbinder, François Lokiec, Mary F. Mulcahy

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after... od Gilles Freyer, P Rougier, R. Bugat, J‐P Droz, Marion Marty, Harry Bleiberg, D. Mignard, Lucile Awad, Patrice Herait, Stéphane Culine, V. Trillet-Lenoir

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Current status of pharmacological treatment of colorectal cancer od Reyhan Akhtar, Shammy Chandel, Pooja Sarotra, Bikash Medhi

Dokumenty pełnotekstowe

Targeted inhibition of <scp>IL</scp>‐18 attenuates irinotecan‐induced intestinal mucositis in mice od Roberto César Pereira Lima‐Júnior, H. Freitas, Deysi Viviana Tenazoa Wong, Carlos W. Wanderley, Luiza Gabrielle Assunção Nunes, Leandro Linhares Leite, Samuel P. Miranda, Marcellus Henrique Loiola Ponte de Souza, Gerly Anne de Castro Brito, Pedro Jorge Caldas Magalhães, Mauro Martins Teixeira, Fernando Q. Cunha, Rita A. Ribeiro

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologu... od Bertrand Brieau, Laëtitia Dahan, Yann De Rycke, Tarek Boussaha, Philippe Vasseur, David Tougeron, Thierry Lecomte, Romain Coriat, Jean‐Baptiste Bachet, Pierre Claudez, Aziz Zaanan, Pauline Soibinet, Jérôme Desramé, Anne Thirot‐Bidault, Isabelle Trouilloud, Florence Mary, Lysiane Marthey, Julien Taı̈eb, Wulfran Cacheux, Astrid Lièvre

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children od Alberto Broniscer, Lisa Iacono, Murali Chintagumpala, Maryam Fouladi, Dana Wallace, Daniel C. Bowers, Clinton F. Stewart, Matthew J. Krasin, Amar Gajjar

Dokumenty pełnotekstowe

Perspectives on Biologically Active Camptothecin Derivatives od Ying-Qian Liu, Wen-Qun Li, Susan L. Morris‐Natschke, Keduo Qian, Yang Liu, Gao-Xiang Zhu, Xiao-Bing Wu, An-Liang Chen, Shao-Yong Zhang, Xiang Nan, Kuo‐Hsiung Lee

Dokumenty pełnotekstowe

Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... od Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio

Dokumenty pełnotekstowe Dokumenty pełnotekstowe

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy od Jennifer A. Crozier, Pooja Advani, Betsy LaPlant, Timothy J. Hobday, Anthony J. Jaslowski, Alvaro Moreno‐Aspitia, Edith A. Perez

Dokumenty pełnotekstowe